Representing Mylan in ANDA litigations over the generic version of Toviaz®. Both litigations, brought within days of each other in differing jurisdictions, involve the same five patents. The cases are set for trial in January 2017.

Pfizer Inc. and UCB Pharma GMBH v. Mylan Pharmaceuticals Inc., No. 15-0079 (D. Del. filed Jan. 23, 2015) and Pfizer Inc. and UCB Pharma GMBH v. Mylan Pharmaceuticals Inc., No. 15-0013-IMK (N.D.W.Va. filed Jan. 27, 2015).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Class action law suit involving commercial truck diesel engines
Represented defendant in class action involving alleged defects in commercial truck diesel engines with exposure in excess of $250,000,000. more
Mutual fund family representation
Providing counsel to the registered investment adviser of a multi-billion dollar real estate investment company and its index mutual fund family. more
ERP licensing & systems integration transactions for private retail company

Represented private retail company in negotiation of agreement with Logic Information Systems to more

Acquisition work for Diageo PLC
Assisted Diageo PLC with various aspects of an acquisition of portions of Seagram Spirits division, including transfer of domain names, performance more